USDCAD is down again this week as its inverse correlation with the price of crude oil seems to have finally returned. Is there a support in sight? Read in our latest Elliott Wave update. <div> <div> To access this article you need to have an active <a href="https://ewminteractive.com/elliott-wave-pro/">subscription</a
Blogs
Tamadoge (TAMA/USD) Price Hovers Lowly, Settling for a Spike
<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>Tamadoge Price Prediction, December 27The present financial status of the economic valuation of Tamadoge versus the worth of the American Dollar reveals that the price hovers lowly around the point of $0.00800, getting set for a
Bitcoin (BTCUSD) May Continue Trading above the Supply Trend Levels
<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>Bitcoin (BTCUSD) Price Forecast: December 27The BTCUSD may continue trading above the supply levels as the crypto is currently running a bullish race facing high pressure from the bulls. Having finished the downward correction,
Lucky Block Price Prediction: LBLOCKUSD May Face Retracement at the $0.0000519 Support Level
<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>Lucky Block Price Prediction – December 27LBLOCKUSD at the moment is preparing for the next jump. The coin price may face retracement at the $0.0000519 current support level for an upward movement soon. Therefore, if the bulls c
Quant (QNTUSD) Looks Tasty for the Bulls
<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>Quant Price Forecast: December 27The Quant (QNTUSD) pair is making positive moves and looks tasty for the bulls as the price now trades very close to the upper resistance level. The crypto can swing up further above the current
EURJPY Exhibits Thinning Activity
<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>The holiday season seems to be exerting a limiting effect on the EURJPY market, restricting price movements. Technical indicators show some divergence, but they might eventually provide support. Key Price Levels: Resistance Leve
Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
<p>Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) — Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) today announced the execution of a definitive agreement for a business combination (the “Transaction” or the
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
<p>NKGen’s SNK01 program continues to show positive progress with the FDA IND clearance in October 2023, and now the CTA clearance by Health Canada for a phase 1/2a clinical trial in moderate Alzheimer’s Disease patients Based on data generated from its Phase I dose escalation safety trial, presented at the recent CTAD conference in October [
Valyant Enters into Settlement Agreement with Hi Auto and kea to Resolve Patent Litigation
<p>Denver, Colo., Dec. 27, 2023 (GLOBE NEWSWIRE) — Valyant AI, Hi Auto, and kea have entered into a settlement agreement to resolve their pending litigation related to Valyant’s patents for voice ordering technology. The terms of the agreement are confidential. With these litigations behind them, Valyant AI, Hi Auto, and kea each will
Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
<p>BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced that the Company’s management team will present at the 42nd Annu